Clin2
NCT07617155Possibly a fitNot yet recruiting

GLP-1 drugs to prevent repeat severe high-triglyceride pancreatitis

Hypertriglyceridemia Induced Acute PancreatitisRecurrent Acute PancreatitisPancreatitis RelapsingHypertriglyceridemia

Treatments studied

Part of Digestive system, Hormones & metabolism clinical trials.

This study tests whether a GLP-1 medication (a drug that helps control blood sugar and triglycerides) can prevent pancreatitis from coming back in people who had a severe attack caused by very high triglyceride levels. If it works, it could help you avoid future painful attacks.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
396 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are at least 18 years old
  • You had a recent severe pancreatitis attack caused by very high triglycerides (over 500–1000 mg/dL in your blood)
  • You are between 4 weeks and 3 months past your hospital discharge with no ongoing pancreatitis symptoms
  • You are willing to make lifestyle changes (diet, exercise) during the study
  • You do not have thyroid cancer, kidney/liver disease, heart disease, or a history of pancreas surgery
  • You are not pregnant or breastfeeding, and agree to use birth control for 20 months if you could become pregnant

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07388420Recruiting
Evolocumab for pancreatitis from high triglycerides

This trial tests adding evolocumab, a medicine that lowers fats in the blood, to standard treatment for people hospitalized with pancreatitis caused by very high triglycerides. The goal is to see if it helps improve recovery.

Shenyang, Liaoning
NCT07693777Not yet recruiting· Phase 3
Testing DR10624 for severe high triglycerides

This trial tests a new injectable drug called DR10624 for people with very high triglyceride levels. It aims to lower triglycerides and reduce the risk of pancreatitis (inflammation of the pancreas).

Shanghai
NCT06185621Recruiting
Aspirin to prevent recurrent pancreatitis

This trial tests if taking aspirin daily can prevent repeated attacks of acute pancreatitis. It's for people who have had at least two episodes of pancreatitis in the past year that were not caused by a medical procedure.

Xi'an, Shaanxi
NCT06253117Recruiting· Phase 2
Testing pirfenidone to prevent repeat pancreatitis attacks

This trial tests if pirfenidone, an anti-scarring drug, can reduce the number of repeat episodes of acute pancreatitis. You may be eligible if you've had two or more pancreatitis attacks at least three months apart and are not having an active attack right now.

Birmingham, Alabama
NCT04647097Recruiting
Quit smoking and alcohol to prevent pancreatitis coming back

This trial is studying whether stopping alcohol and quitting smoking can help keep acute pancreatitis from returning. It’s for people whose pancreatitis happened because of alcohol, and who smoke every day.

Pécs
NCT06976099Enrolling by invitation
Studying pancreatitis caused by high triglycerides

This study looks at people with acute pancreatitis caused by very high blood fat levels (triglycerides). It aims to collect information to better understand and treat this condition.

Beijing, Beijing Municipality

Hear when a new Recurrent Acute Pancreatitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.